Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
12.91
+0.28 (2.22%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Bioventus Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,086 | 498 | 686 | 332 | 162 | 861 | |
Market Cap Growth | 134.19% | -27.40% | 106.84% | 105.22% | -81.23% | - |
Enterprise Value | 1,319 | 838 | 1,086 | 775 | 605 | 1,054 |
Last Close Price | 12.91 | 7.44 | 10.50 | 5.27 | 2.61 | 14.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.51 | 21.92 | - | - | - | - |
Forward PE | 16.19 | 9.79 | 20.00 | 21.82 | 17.17 | 21.50 |
PS Ratio | 1.87 | 0.88 | 1.20 | 0.65 | 0.32 | 2.00 |
PB Ratio | 3.86 | 2.18 | 3.70 | 1.50 | 0.39 | 1.61 |
P/FCF Ratio | 11.51 | 6.91 | 18.16 | 41.57 | - | 90.94 |
P/OCF Ratio | 11.21 | 6.67 | 17.69 | 21.63 | - | 37.46 |
PEG Ratio | 1.47 | 0.82 | 0.82 | 0.82 | 0.82 | 2.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.27 | 1.48 | 1.90 | 1.51 | 1.18 | 2.45 |
EV/EBITDA Ratio | 16.46 | 10.80 | 19.48 | 26.88 | - | 25.38 |
EV/EBIT Ratio | 21.76 | 14.88 | 29.66 | 382.69 | - | 50.07 |
EV/FCF Ratio | 13.99 | 11.63 | 28.75 | 97.14 | - | 111.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.95 | 1.36 | 1.92 | 1.90 | 1.06 | 0.71 |
Debt / EBITDA Ratio | 3.08 | 3.74 | 5.79 | 11.81 | 719.64 | 8.23 |
Debt / FCF Ratio | 2.80 | 4.32 | 9.42 | 52.70 | - | 39.72 |
Net Debt / Equity Ratio | 0.84 | 1.14 | 1.69 | 1.74 | 0.99 | 0.62 |
Net Debt / EBITDA Ratio | 2.91 | 3.35 | 5.64 | 13.30 | -86.70 | 8.00 |
Net Debt / FCF Ratio | 2.48 | 3.61 | 8.32 | 48.07 | -16.20 | 35.09 |
Asset Turnover | 0.84 | 0.81 | 0.75 | 0.47 | 0.39 | 0.50 |
Inventory Turnover | 2.07 | 2.06 | 2.01 | 2.09 | 2.47 | 2.82 |
Quick Ratio | 1.11 | 1.12 | 0.80 | 0.91 | 0.55 | 0.93 |
Current Ratio | 1.69 | 1.70 | 1.31 | 1.53 | 0.90 | 1.46 |
Return on Equity (ROE) | 25.68% | 13.17% | -23.14% | -38.27% | -30.58% | 3.38% |
Return on Assets (ROA) | 5.49% | 4.99% | 2.97% | 0.12% | -1.67% | 1.53% |
Return on Invested Capital (ROIC) | 12.15% | 11.40% | 6.63% | 0.29% | -4.12% | 3.73% |
Return on Capital Employed (ROCE) | 11.60% | 10.80% | 7.10% | 0.30% | -3.20% | 2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.02% | 4.56% | -5.26% | -47.08% | -98.15% | 2.25% |
FCF Yield | 8.68% | 14.47% | 5.51% | 2.40% | -15.50% | 1.10% |
Buyback Yield / Dilution | -5.97% | -6.77% | -3.03% | -2.05% | -35.00% | -828.01% |